The ATM program signals ongoing cash needs and potential dilution. With the stock trading at $0.87, well below the $1.42 reference price, any sales will be highly dilutive. Monitor the company's cash burn rate and next quarterly filing for updates on share count and cash position.
SNGX drugs
SNGX drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · May 29 $0.9100entry
- T+1 · 6mo ago −9.31%α −9.58% · $0.8253
- T+5 · 6mo ago −47.25%α −46.96% · $0.4800
- T+20 · 5mo ago −56.04%α −54.25% · $0.4000
- T+60 · 3mo ago −55.53%α −56.71% · $0.4047
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Soligenix filed a 424B5 prospectus supplement to update the maximum dollar amount of common stock it can sell under its existing at-the-market (ATM) sales agreement with Rodman & Renshaw. The company may now offer and sell up to $2,956,000 in additional common stock, subject to the one-third public float limitation under General Instruction I.B.6 of Form S-3. The stock closed at $0.87 per share on May 27, 2026, representing a significant discount to the $1.42 reference price used to calculate the public float.
Key Facts
- Soligenix may sell up to $2,956,000 in additional common stock under its ATM agreement with Rodman & Renshaw.
- The public float is $24,511,625 based on 17,261,708 non-affiliate shares at $1.42 per share (April 27, 2026).
- The stock closed at $0.87 per share on May 27, 2026, a 39% decline from the $1.42 reference price.
- The company has already sold $5,214,498 in securities under General Instruction I.B.6 in the prior 12 months.
- The offering is limited to one-third of the public float in any 12-month period under General Instruction I.B.6.
- Soligenix is a smaller reporting company with a market cap of approximately $13 million.
Financial Impact
Up to $2,956,000 in potential dilution at current market prices, representing approximately 22.7% of the current market cap of $13 million.
Risk Factors
- Significant dilution to existing shareholders if shares are sold at current depressed prices.
- The company may need to raise additional capital beyond this ATM, further pressuring the stock.
- Low stock price and small market cap increase volatility and risk of delisting from Nasdaq.
- The company has already sold $5.2 million under the shelf in the prior 12 months, indicating persistent cash needs.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001104659-26-067644 |
| Document: 0001104659-26-067644-index-headers.html | 0001104659-26-067644 |
| Document: 0001104659-26-067644-index.html | 0001104659-26-067644 |
| Document: 0001104659-26-067644.txt | 0001104659-26-067644 |
Track record
7 reports on SNGX
4 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +69.30% at T+20 after the Apr 3, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $0.3350 Now $0.2900 −13.43% settles Feb 4
- Nov 2, 202614d ago SC 13G/A Neutral 2/10 Entry $0.3612 Now $0.2900 −19.71% settles Jan 29
- Jun 26, 202620w ago 8-K Bearish 6/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- Jun 26, 202620w ago 424B5 Bearish 7/10 Entry $0.4000 to $0.3850 Now $0.2900 +27.50% ▲ +3.75% +8.14% vs SPY
- May 28, 202624w ago 8-K Bearish 5/10 Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- May 28, 202624w ago 424B5 Bearish 6/10 Viewing Entry $0.9100 to $0.4047 Now $0.2900 +68.13% ▲ +55.53% +56.71% vs SPY
- Apr 3, 202632w ago EFFECT Bearish 6/10 Entry $1.14 to $0.3970 Now $0.2900 +74.56% ▲ +65.18% +78.64% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers